Hospira Recalls Ondansetron Injection Vials Due to Glass Spicules
Hospira Inc. is recalling 681,400 vials of Ondansetron Injection because glass spicules were found during a site inspection.
- Product
- ONDANSETRON — ONDANSETRON (ONDANSETRON)
- Category
- Drug
- Distribution
- Distributed nationwide